CCM2_W421AD422A_eGFP
(Plasmid
#208880)
-
PurposeExpress eGFP-CCM2 with the W421A and D422A mutations in mammalian cells.
-
Depositing Lab
-
Publication
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 208880 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcDNA3.1(+)-N-eGFP
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameCCM2
-
SpeciesH. sapiens (human)
-
Mutationmutations W421A and D422A
-
Entrez GeneCCM2 (a.k.a. C7orf22, OSM, PP10187)
-
Tag
/ Fusion Protein
- eGFP
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BamHI (unknown if destroyed)
- 3′ cloning site XhoI (unknown if destroyed)
- 5′ sequencing primer CMV (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made byThis construct was purchased from GenScript. Briefly, the gene fragments were synthesized using gene synthesis and cloned into pcDNA3.1(+)-N-eGFP using the BamHI/XhoI sites.
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
CCM2_W421AD422A_eGFP was a gift from Guillaume Jacquemet (Addgene plasmid # 208880 ; http://n2t.net/addgene:208880 ; RRID:Addgene_208880) -
For your References section:
TLNRD1 is a CCM complex component and regulates endothelial barrier integrity. Neil J. Ball, Sujan Ghimire, Gautier Follain, Ada O. Pajari, Monika Vaitkevičiūtė, Alana R. Cowell, Bence Berki, Johanna Ivaska, ProfileIlkka Paatero, Benjamin T. Goult, Guillaume Jacquemet. BioRxiv 10.1101/2023.09.29.559344